Your Health, We Care
Anagrelide was first marketed in the United States in 1997Anagrel was developedby Roberts in United States and first marketed in the United States in 1997under the trade name Agrylin.
Anagrelide received marketing approval from the European Union, Iceland andNorway in November 2004. In addition, the drug was marketed in Hong Kong, Chinain 2005, but is not currently available in Chinese mainland.
